top of page
Search

In The News: "Making the Most of the Rising Biopharma M&A"

  • Bethany Valente
  • Jul 26, 2021
  • 1 min read

Dr. Valente, our Managing Partner and Co-Founder, contributed to the conversation with Pharmaceutial Executive (https://bit.ly/3i5p203) about how to overcome common roadblocks to global expansion in Pharma and Biotech.


"Last year was a down year for mergers and acquisitions (M&As) because of the pandemic, but biopharma deal-making is once again on the rise, evidenced by Gilead Sciences finalizing its purchase of Immunomedics. Gilead is one of many global biopharmaceutical companies hoping to find footing in the United States for two reasons: Biotech innovation has skyrocketed and U.S. tax penalties have been mitigated."


To learn more, read the article at:

 
 
 

Recent Posts

See All
Let's Get Inspired. Together.

“The Sweetest Boat This Side of Heaven” Owner: Guy Lombardo Builder: Les Staudcher Driver: Danny Foster Tempo VII won 6 first place...

 
 

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.
Post: Blog2 Post
bottom of page